<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d18" origId="Isotretinoin"><sentence id="DrugDDI.d18.s0" origId="s0" text="? Vitamin A: Because of the relationship of Accutane to vitamin A, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects"><entity id="DrugDDI.d18.s0.e0" origId="s0.p0" charOffset="2-11" type="drug" text="Vitamin A"/><entity id="DrugDDI.d18.s0.e1" origId="s0.p3" charOffset="44-52" type="drug" text="Accutane"/><entity id="DrugDDI.d18.s0.e2" origId="s0.p4" charOffset="56-65" type="drug" text="vitamin A"/><entity id="DrugDDI.d18.s0.e3" origId="s0.p11" charOffset="140-149" type="drug" text="vitamin A"/><pair id="DrugDDI.d18.s0.p0" e1="DrugDDI.d18.s0.e0" e2="DrugDDI.d18.s0.e1" interaction="false"/><pair id="DrugDDI.d18.s0.p1" e1="DrugDDI.d18.s0.e0" e2="DrugDDI.d18.s0.e2" interaction="false"/><pair id="DrugDDI.d18.s0.p2" e1="DrugDDI.d18.s0.e0" e2="DrugDDI.d18.s0.e3" interaction="false"/><pair id="DrugDDI.d18.s0.p3" e1="DrugDDI.d18.s0.e1" e2="DrugDDI.d18.s0.e2" interaction="true"/><pair id="DrugDDI.d18.s0.p4" e1="DrugDDI.d18.s0.e1" e2="DrugDDI.d18.s0.e3" interaction="false"/><pair id="DrugDDI.d18.s0.p5" e1="DrugDDI.d18.s0.e2" e2="DrugDDI.d18.s0.e3" interaction="false"/></sentence><sentence id="DrugDDI.d18.s1" origId="s1" text="."/><sentence id="DrugDDI.d18.s2" origId="s2" text="? Tetracyclines: Concomitant treatment with Accutane and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines"><entity id="DrugDDI.d18.s2.e0" origId="s2.p14" charOffset="2-15" type="drug" text="Tetracyclines"/><entity id="DrugDDI.d18.s2.e1" origId="s2.p17" charOffset="44-52" type="drug" text="Accutane"/><entity id="DrugDDI.d18.s2.e2" origId="s2.p19" charOffset="57-70" type="drug" text="tetracyclines"/><entity id="DrugDDI.d18.s2.e3" origId="s2.p24" charOffset="97-105" type="drug" text="Accutane"/><entity id="DrugDDI.d18.s2.e4" origId="s2.p39" charOffset="254-267" type="drug" text="tetracyclines"/><pair id="DrugDDI.d18.s2.p0" e1="DrugDDI.d18.s2.e0" e2="DrugDDI.d18.s2.e1" interaction="false"/><pair id="DrugDDI.d18.s2.p1" e1="DrugDDI.d18.s2.e0" e2="DrugDDI.d18.s2.e2" interaction="false"/><pair id="DrugDDI.d18.s2.p2" e1="DrugDDI.d18.s2.e0" e2="DrugDDI.d18.s2.e3" interaction="false"/><pair id="DrugDDI.d18.s2.p3" e1="DrugDDI.d18.s2.e0" e2="DrugDDI.d18.s2.e4" interaction="false"/><pair id="DrugDDI.d18.s2.p4" e1="DrugDDI.d18.s2.e1" e2="DrugDDI.d18.s2.e2" interaction="true"/><pair id="DrugDDI.d18.s2.p5" e1="DrugDDI.d18.s2.e1" e2="DrugDDI.d18.s2.e3" interaction="false"/><pair id="DrugDDI.d18.s2.p6" e1="DrugDDI.d18.s2.e1" e2="DrugDDI.d18.s2.e4" interaction="false"/><pair id="DrugDDI.d18.s2.p7" e1="DrugDDI.d18.s2.e2" e2="DrugDDI.d18.s2.e3" interaction="false"/><pair id="DrugDDI.d18.s2.p8" e1="DrugDDI.d18.s2.e2" e2="DrugDDI.d18.s2.e4" interaction="false"/><pair id="DrugDDI.d18.s2.p9" e1="DrugDDI.d18.s2.e3" e2="DrugDDI.d18.s2.e4" interaction="false"/></sentence><sentence id="DrugDDI.d18.s3" origId="s3" text="."/><sentence id="DrugDDI.d18.s4" origId="s4" text="? Micro-dosed Progesterone Preparations: Micro-dosed progesterone preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during Accutane therapy."><entity id="DrugDDI.d18.s4.e0" origId="s4.p40" charOffset="14-38" type="drug" text="Progesterone Preparation"/><entity id="DrugDDI.d18.s4.e1" origId="s4.p42" charOffset="53-77" type="drug" text="progesterone preparation"/><entity id="DrugDDI.d18.s4.e2" origId="s4.p49" charOffset="113-121" type="drug" text="estrogen"/><entity id="DrugDDI.d18.s4.e3" origId="s4.p55" charOffset="175-183" type="drug" text="Accutane"/><pair id="DrugDDI.d18.s4.p0" e1="DrugDDI.d18.s4.e0" e2="DrugDDI.d18.s4.e1" interaction="false"/><pair id="DrugDDI.d18.s4.p1" e1="DrugDDI.d18.s4.e0" e2="DrugDDI.d18.s4.e2" interaction="false"/><pair id="DrugDDI.d18.s4.p2" e1="DrugDDI.d18.s4.e0" e2="DrugDDI.d18.s4.e3" interaction="false"/><pair id="DrugDDI.d18.s4.p3" e1="DrugDDI.d18.s4.e1" e2="DrugDDI.d18.s4.e2" interaction="false"/><pair id="DrugDDI.d18.s4.p4" e1="DrugDDI.d18.s4.e1" e2="DrugDDI.d18.s4.e3" interaction="true"/><pair id="DrugDDI.d18.s4.p5" e1="DrugDDI.d18.s4.e2" e2="DrugDDI.d18.s4.e3" interaction="false"/></sentence><sentence id="DrugDDI.d18.s5" origId="s5" text="Although other hormonal contraceptives are highly effective, there have been reports of pregnancy from women who have used combined oral contraceptives, as well as topical/injectable/implantable/insertable hormonal birth control products."><entity id="DrugDDI.d18.s5.e0" origId="s5.p57" charOffset="24-38" type="drug" text="contraceptives"/><entity id="DrugDDI.d18.s5.e1" origId="s5.p69" charOffset="132-151" type="drug" text="oral contraceptives"/><entity id="DrugDDI.d18.s5.e2" origId="s5.p74" charOffset="215-228" type="drug" text="birth control"/><pair id="DrugDDI.d18.s5.p0" e1="DrugDDI.d18.s5.e0" e2="DrugDDI.d18.s5.e1" interaction="false"/><pair id="DrugDDI.d18.s5.p1" e1="DrugDDI.d18.s5.e0" e2="DrugDDI.d18.s5.e2" interaction="false"/><pair id="DrugDDI.d18.s5.p2" e1="DrugDDI.d18.s5.e1" e2="DrugDDI.d18.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d18.s6" origId="s6" text="These reports are more frequent for women who use only a single method of contraception."/><sentence id="DrugDDI.d18.s7" origId="s7" text="It is not known if hormonal contraceptives differ in their effectiveness when used with Accutane."><entity id="DrugDDI.d18.s7.e0" origId="s7.p87" charOffset="28-42" type="drug" text="contraceptives"/><entity id="DrugDDI.d18.s7.e1" origId="s7.p92" charOffset="88-96" type="drug" text="Accutane"/><pair id="DrugDDI.d18.s7.p0" e1="DrugDDI.d18.s7.e0" e2="DrugDDI.d18.s7.e1" interaction="false"/></sentence><sentence id="DrugDDI.d18.s8" origId="s8" text="Therefore, it is critically important for women of childbearing potential to select and commit to use 2 forms of effective contraception simultaneously, at least 1 of which must be a primary form, unless absolute abstinence is the chosen method, or the patient has undergone a hysterectomy"><entity id="DrugDDI.d18.s8.e0" origId="s8.p101" charOffset="88-94" type="drug" text="commit"/></sentence><sentence id="DrugDDI.d18.s9" origId="s9" text="."/><sentence id="DrugDDI.d18.s10" origId="s10" text="? Phenytoin: Accutane has not been shown to alter the pharmacokinetics of phenytoin in a study in seven healthy volunteers."><entity id="DrugDDI.d18.s10.e0" origId="s10.p120" charOffset="2-11" type="drug" text="Phenytoin"/><entity id="DrugDDI.d18.s10.e1" origId="s10.p122" charOffset="13-21" type="drug" text="Accutane"/><entity id="DrugDDI.d18.s10.e2" origId="s10.p130" charOffset="74-83" type="drug" text="phenytoin"/><pair id="DrugDDI.d18.s10.p0" e1="DrugDDI.d18.s10.e0" e2="DrugDDI.d18.s10.e1" interaction="false"/><pair id="DrugDDI.d18.s10.p1" e1="DrugDDI.d18.s10.e0" e2="DrugDDI.d18.s10.e2" interaction="false"/><pair id="DrugDDI.d18.s10.p2" e1="DrugDDI.d18.s10.e1" e2="DrugDDI.d18.s10.e2" interaction="false"/></sentence><sentence id="DrugDDI.d18.s11" origId="s11" text="These results are consistent with the in vitro finding that neither isotretinoin nor its metabolites induce or inhibit the activity of the CYP 2C9 human hepatic P450 enzyme."><entity id="DrugDDI.d18.s11.e0" origId="s11.p140" charOffset="68-80" type="drug" text="isotretinoin"/><entity id="DrugDDI.d18.s11.e1" origId="s11.p142" charOffset="89-100" type="drug" text="metabolites"/><entity id="DrugDDI.d18.s11.e2" origId="s11.p147" charOffset="139-146" type="drug" text="CYP 2C9"/><pair id="DrugDDI.d18.s11.p0" e1="DrugDDI.d18.s11.e0" e2="DrugDDI.d18.s11.e1" interaction="false"/><pair id="DrugDDI.d18.s11.p1" e1="DrugDDI.d18.s11.e0" e2="DrugDDI.d18.s11.e2" interaction="false"/><pair id="DrugDDI.d18.s11.p2" e1="DrugDDI.d18.s11.e1" e2="DrugDDI.d18.s11.e2" interaction="false"/></sentence><sentence id="DrugDDI.d18.s12" origId="s12" text="Phenytoin is known to cause osteomalacia."><entity id="DrugDDI.d18.s12.e0" origId="s12.p148" charOffset="0-9" type="drug" text="Phenytoin"/></sentence><sentence id="DrugDDI.d18.s13" origId="s13" text="No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between phenytoin and Accutane."><entity id="DrugDDI.d18.s13.e0" origId="s13.p164" charOffset="112-121" type="drug" text="phenytoin"/><entity id="DrugDDI.d18.s13.e1" origId="s13.p166" charOffset="126-134" type="drug" text="Accutane"/><pair id="DrugDDI.d18.s13.p0" e1="DrugDDI.d18.s13.e0" e2="DrugDDI.d18.s13.e1" interaction="false"/></sentence><sentence id="DrugDDI.d18.s14" origId="s14" text="Therefore, caution should be exercised when using these drugs together"><entity id="DrugDDI.d18.s14.e0" origId="s14.p174" charOffset="56-61" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d18.s15" origId="s15" text="."/><sentence id="DrugDDI.d18.s16" origId="s16" text="? Systemic Corticosteroids: Systemic corticosteroids are known to cause osteoporosis."><entity id="DrugDDI.d18.s16.e0" origId="s16.p175" charOffset="11-26" type="drug" text="Corticosteroids"/><entity id="DrugDDI.d18.s16.e1" origId="s16.p177" charOffset="37-52" type="drug" text="corticosteroids"/><pair id="DrugDDI.d18.s16.p0" e1="DrugDDI.d18.s16.e0" e2="DrugDDI.d18.s16.e1" interaction="false"/></sentence><sentence id="DrugDDI.d18.s17" origId="s17" text="No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between systemic corticosteroids and Accutane."><entity id="DrugDDI.d18.s17.e0" origId="s17.p193" charOffset="121-136" type="drug" text="corticosteroids"/><entity id="DrugDDI.d18.s17.e1" origId="s17.p195" charOffset="141-149" type="drug" text="Accutane"/><pair id="DrugDDI.d18.s17.p0" e1="DrugDDI.d18.s17.e0" e2="DrugDDI.d18.s17.e1" interaction="false"/></sentence><sentence id="DrugDDI.d18.s18" origId="s18" text="Therefore, caution should be exercised when using these drugs together."><entity id="DrugDDI.d18.s18.e0" origId="s18.p203" charOffset="56-61" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d18.s19" origId="s19" text="Prescribers are advised to consult the package insert of medication administered concomitantly with hormonal contraceptives, since some medications may decrease the effectiveness of these birth control products."><entity id="DrugDDI.d18.s19.e0" origId="s19.p210" charOffset="57-68" type="drug" text="medication"/><entity id="DrugDDI.d18.s19.e1" origId="s19.p213" charOffset="109-123" type="drug" text="contraceptives"/><entity id="DrugDDI.d18.s19.e2" origId="s19.p215" charOffset="136-147" type="drug" text="medications"/><entity id="DrugDDI.d18.s19.e3" origId="s19.p219" charOffset="188-201" type="drug" text="birth control"/><pair id="DrugDDI.d18.s19.p0" e1="DrugDDI.d18.s19.e0" e2="DrugDDI.d18.s19.e1" interaction="true"/><pair id="DrugDDI.d18.s19.p1" e1="DrugDDI.d18.s19.e0" e2="DrugDDI.d18.s19.e2" interaction="false"/><pair id="DrugDDI.d18.s19.p2" e1="DrugDDI.d18.s19.e0" e2="DrugDDI.d18.s19.e3" interaction="false"/><pair id="DrugDDI.d18.s19.p3" e1="DrugDDI.d18.s19.e1" e2="DrugDDI.d18.s19.e2" interaction="false"/><pair id="DrugDDI.d18.s19.p4" e1="DrugDDI.d18.s19.e1" e2="DrugDDI.d18.s19.e3" interaction="false"/><pair id="DrugDDI.d18.s19.p5" e1="DrugDDI.d18.s19.e2" e2="DrugDDI.d18.s19.e3" interaction="false"/></sentence><sentence id="DrugDDI.d18.s20" origId="s20" text="Accutane use is associated with depression in some patients."><entity id="DrugDDI.d18.s20.e0" origId="s20.p220" charOffset="0-8" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s21" origId="s21" text="Patients should be prospectively cautioned not to self-medicate with the herbal supplement St. John?s Wort because a possible interaction has been suggested with hormonal contraceptives based on reports of breakthrough bleeding on oral contraceptives shortly after starting St. Johns Wort."><entity id="DrugDDI.d18.s21.e0" origId="s21.p239" charOffset="171-185" type="drug" text="contraceptives"/><entity id="DrugDDI.d18.s21.e1" origId="s21.p243" charOffset="231-250" type="drug" text="oral contraceptives"/><entity id="DrugDDI.d18.s21.e2" origId="s21.p246" charOffset="274-288" type="drug" text="St. Johns Wort"/><pair id="DrugDDI.d18.s21.p0" e1="DrugDDI.d18.s21.e0" e2="DrugDDI.d18.s21.e1" interaction="false"/><pair id="DrugDDI.d18.s21.p1" e1="DrugDDI.d18.s21.e0" e2="DrugDDI.d18.s21.e2" interaction="false"/><pair id="DrugDDI.d18.s21.p2" e1="DrugDDI.d18.s21.e1" e2="DrugDDI.d18.s21.e2" interaction="true"/></sentence><sentence id="DrugDDI.d18.s22" origId="s22" text="Pregnancies have been reported by users of combined hormonal contraceptives who also used some form of St. Johns Wort."><entity id="DrugDDI.d18.s22.e0" origId="s22.p252" charOffset="61-75" type="drug" text="contraceptives"/><entity id="DrugDDI.d18.s22.e1" origId="s22.p256" charOffset="103-118" type="drug" text="St. Johns Wort"/><pair id="DrugDDI.d18.s22.p0" e1="DrugDDI.d18.s22.e0" e2="DrugDDI.d18.s22.e1" interaction="true"/></sentence><sentence id="DrugDDI.d18.s23" origId="s23" text="Laboratory Tests Pregnancy Test Female patients of childbearing potential must have negative results from 2 urine or serum pregnancy tests with a sensitivity of at least 25 mIU/mL before receiving the initial Accutane prescription."><entity id="DrugDDI.d18.s23.e0" origId="s23.p271" charOffset="209-217" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s24" origId="s24" text="The first test is obtained by the prescriber when the decision is made to pursue qualification of the patient for Accutane (a screening test)."><entity id="DrugDDI.d18.s24.e0" origId="s24.p284" charOffset="114-122" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s25" origId="s25" text="The second pregnancy test (a confirmation test) should be done during the first 5 days of the menstrual period immediately preceding the beginning of Accutane therapy."><entity id="DrugDDI.d18.s25.e0" origId="s25.p299" charOffset="150-158" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s26" origId="s26" text="For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception)."/><sentence id="DrugDDI.d18.s27" origId="s27" text="Each month of therapy, the patient must have a negative result from a urine or serum pregnancy test."/><sentence id="DrugDDI.d18.s28" origId="s28" text="A pregnancy test must be repeated each month prior to the female patient receiving each prescription"/><sentence id="DrugDDI.d18.s29" origId="s29" text="."/><sentence id="DrugDDI.d18.s30" origId="s30" text="? Lipids: Pretreatment and follow-up blood lipids should be obtained under fasting conditions."/><sentence id="DrugDDI.d18.s31" origId="s31" text="After consumption of alcohol, at least 36 hours should elapse before these determinations are made."><entity id="DrugDDI.d18.s31.e0" origId="s31.p343" charOffset="21-28" type="drug" text="alcohol"/></sentence><sentence id="DrugDDI.d18.s32" origId="s32" text="It is recommended that these tests be performed at weekly or biweekly intervals until the lipid response to Accutane is established."><entity id="DrugDDI.d18.s32.e0" origId="s32.p360" charOffset="108-116" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s33" origId="s33" text="The incidence of hypertriglyceridemia is 1 patient in 4 on Accutane therapy"><entity id="DrugDDI.d18.s33.e0" origId="s33.p368" charOffset="59-67" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s34" origId="s34" text="."/><sentence id="DrugDDI.d18.s35" origId="s35" text="? Liver Function Tests: Since elevations of liver enzymes have been observed during clinical trials, and hepatitis has been reported, pretreatment and follow-up liver function tests should be performed at weekly or biweekly intervals until the response to Accutane has been established"><entity id="DrugDDI.d18.s35.e0" origId="s35.p373" charOffset="44-57" type="drug" text="liver enzymes"/><entity id="DrugDDI.d18.s35.e1" origId="s35.p394" charOffset="256-264" type="drug" text="Accutane"/><pair id="DrugDDI.d18.s35.p0" e1="DrugDDI.d18.s35.e0" e2="DrugDDI.d18.s35.e1" interaction="false"/></sentence><sentence id="DrugDDI.d18.s36" origId="s36" text="."/><sentence id="DrugDDI.d18.s37" origId="s37" text="? Glucose: Some patients receiving Accutane have experienced problems in the control of their blood sugar."><entity id="DrugDDI.d18.s37.e0" origId="s37.p398" charOffset="2-9" type="drug" text="Glucose"/><entity id="DrugDDI.d18.s37.e1" origId="s37.p402" charOffset="35-43" type="drug" text="Accutane"/><pair id="DrugDDI.d18.s37.p0" e1="DrugDDI.d18.s37.e0" e2="DrugDDI.d18.s37.e1" interaction="false"/></sentence><sentence id="DrugDDI.d18.s38" origId="s38" text="In addition, new cases of diabetes have been diagnosed during Accutane therapy, although no causal relationship has been established"><entity id="DrugDDI.d18.s38.e0" origId="s38.p413" charOffset="62-70" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s39" origId="s39" text="."/><sentence id="DrugDDI.d18.s40" origId="s40" text="? CPK: Some patients undergoing vigorous physical activity while on Accutane therapy have experienced elevated CPK levels;"><entity id="DrugDDI.d18.s40.e0" origId="s40.p423" charOffset="68-76" type="drug" text="Accutane"/></sentence><sentence id="DrugDDI.d18.s41" origId="s41" text="however, the clinical significance is unknown."/><sentence id="DrugDDI.d18.s42" origId="s42" text="There have been rare postmarketing reports of rhabdomyolysis, some associated with strenuous physical activity."/><sentence id="DrugDDI.d18.s43" origId="s43" text="In a clinical trial of 217 pediatric patients (12 to 17 years) with severe recalcitrant nodular acne, transient elevations in CPK were observed in 12% of patients, including those undergoing strenuous physical activity in association with reported musculoskeletal adverse events such as back pain, arthralgia, limb injury, or muscle sprain."><entity id="DrugDDI.d18.s43.e0" origId="s43.p441" charOffset="27-36" type="drug" text="pediatric"/></sentence><sentence id="DrugDDI.d18.s44" origId="s44" text="In these patients, approximately half of the CPK elevations returned to normal within 2 weeks and half returned to normal within 4 weeks."/><sentence id="DrugDDI.d18.s45" origId="s45" text="No cases of rhabdomyolysis were reported in this trial."/></document>